Ligand validation:9CJ4

B96: 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA

B96 is a Ligand Of Interest in 9CJ4 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9CJ4_B96_A_401	94%	1%	0.06	0.959	5	3.37	20	24	0	0	100%	1
5N66_B96_A_402	16%	35%	0.241	0.815	1.45	1.13	5	4	2	0	100%	1
3NPC_B96_A_365	74%	43%	0.133	0.963	0.84	1.34	2	7	0	0	100%	1
3FZS_B96_A_999	60%	27%	0.111	0.896	0.89	2.02	-	8	1	0	100%	1
4JVG_B96_C_801	51%	28%	0.215	0.971	1.44	1.44	4	7	4	0	100%	1
6GTT_B96_A_500	46%	54%	0.165	0.901	0.79	0.99	2	6	1	0	100%	1
8YGW_B96_A_401	29%	57%	0.301	0.962	0.74	0.91	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.